Introduction
Acute renal failure (ARF) is mainly caused by renal ischemia or nephrotoxic agents. It is characterized by severe reduction in glomerular filtration rate (GFR), urinary concentrating ability, and impaired tubular reabsorption of sodium. A diminished adenylate cyclase activity and aquaporin-2 (AQP2) expression may contribute to the urinary concentration defect in post-ischemic kidneys 1) . Several studies reported defects in the collecting duct sodium handling in ischemia/reperfusion (I/R)-induced ARF rats 2, 3) .
Although the mechanisms underlying intrarenal vasoconstriction and hypoperfusion remain incompletely defined, an imbalance of vasoactive agents such as endothelin and nitric oxide may be contributory 4) . On the other hand, the tubular cell damage may be caused by such factors as ATP depletion, intracellular calcium, oxygen free radicals and apoptosis 5) .
Under normal circumstances, the kidney generates reactive oxygen species (ROS), including superoxide anions, hydrogen peroxide, peroxynitrite and hydroxyl radical, which are efficiently eliminated by enzymatic-superoxide dismutase (SOD), catalase, glutathione peroxidase (GPX)-and non-enzymatic systems (glutathione, Vitamins C and E). Oxidative stress occurs when ROS production overrides metabolic capacity of the antioxidant defense system, often resulting in tissue damage ( Fig. 1 . It also has been demonstrated that LA .
The tubular reabsorption of solutes is basically linked to the activity of Na,K-ATPase that is heavily expressed in the basolateral membrane throughout the nephron segments. On the contrary, the sodium transporters in the apical membrane differ in different tubular segments.
In the proximal tubule, type-3 Na-H exchanger (NHE3) is apically expressed. On the other hand, the apically expressed bumetanide-sensitive Na-K-2Cl cotransporters (NKCC2) and NHE3 are mainly responsible for the sodium reabsorption in the thick ascending loop of Henle (TAL). In the distal convoluted tubule, the thiazide-sensitive sodium chloride cotransporter (NCC)
is involved in the apical movement of sodium [14] [15] [16] .
Changes of AQP and sodium transporters in ischemia/reperfusion renal injury and cisplatin induced nephropathy
Ichemia/reperfusion renal injury
The urinary concentration defect and increased water excretion is, at least in part, accounted for by a reduced abundance of AQP2 water channels in the collecting duct .
Cisplatin-induced nephropathy
Cisplatin is highly efficacious in treating a wide variety of neoplastic disease 20) . However, its clinical use is often limited by its potential renal toxicity leading to ARF [21] [22] [23] . The most silent and persistent features of cisplatin-induced nephropathy is polyuria and inability to concentrate urine 24) . We have demonstrated that cisplatin-treatment caused polyuric renal failure in association with decrease in free water reabsorption 25) . The expression of AQP1 and AQP2 was decreased in the cortex, outer medulla and inner medulla, whereas that of AQP3 was decreased in the outer medulla and the inner medulla. Immunohistochemistry also revealed that cisplatin decreased immunoreactivity for AQP1, AQP2, and AQP3. The AVP evoked generation of cAMP was attenuated by cisplatin, being most prominent in the outer medulla.
Effects of α-LA on the dysregulation of AQP and sodium transporters ARF was ameliorated by treatment with -LA at α the time of ischemia 26) . Accordingly, the creatinine clearance was increased. Furthermore, -LA treat α -ment attenuated the polyuria that was encountered in the post-ischemic period, along with normally expressed abundance of AQP1-3. The reduced expression of NHE3 and Na,K-ATPase and the increase in 
